Balancing a Family and an Emerging Career in Public Health

News
Video

Public health researchers highlight how they learned to overcome and adapt to disparities observed during their careers.

In many fields across the cancer care space, there are disparities observed between men and women. When working as a woman in a male-dominated field such as public health and balancing both professional and personal responsibilities, the disparities may become a bit clearer.

In a recent CancerNetwork® Breaking Barriers: Women in Oncology segment, Cathy Bradley, PhD, and Lindsay M. Sabik, PhD, discussed how they have observed these disparities in their day-to-day careers.

Bradley, dean and professor at Colorado School of Public Health and Deputy Director of the University of Colorado Cancer Center; and Sabik, associate professor and Vice Chair for Research in Health Policy Management at the University of Pittsburgh School of Public Health and a member of the UPMC Hillman Cancer Center, highlighted how beginning families and juggling other personal tasks in the midst of their careers have impacted their lives.

Transcript:

Bradley:

[When] beginning my career, I started a family right away. After accepting my first academic position, my first son was born within that year. It’s just hard. It’s just a difficult thing to take care of small children, go through pregnancy, and deal with those kinds of things. Later in my career, I helped to take care of my parents until they passed away while my children were still young and dependent. [Public health] is just a very difficult, competitive thing. Academia is opening up a little bit more since I started my career in talking about those issues, and the COVID-19 [pandemic] opened up more of those conversations. But the proportion of work [at home] is still largely handled by women.

Sabik:

I would echo that both on the professional side and the personal [side]. [Considering the] societal conventions about the role that women play, and the way that we’ve grown up as women in society, we tend to sometimes experience an undue burden on both the professional and personal side. Having to continually try to prioritize, face those challenges, and make sure that we’re able to focus on the things that we need to and not get overwhelmed are always challenges.

Recent Videos
According to John Henson, MD, “What we need are better treatments to control the [brain] tumor once it’s detected.”
First-degree relatives of patients who passed away from pancreatic cancer should be genetically tested to identify their risk for the disease.
Destigmatizing cancer care for incarcerated patients may help ensure that they feel supported both in their treatment and their humanity.
A lower percentage of patients who were released within 1 year of incarceration received guideline-concurrent care vs incarcerated patients.
A collaboration between the Connecticut Departments of Health and Corrections and the COPPER Center aimed to improve outcomes among incarcerated patients.
Computational models help researchers anticipate how ADCs may behave in later lines of development, while they are still in the early stages.
ADC payloads with high levels of potency can sometimes lead to higher levels of toxicity, which can eliminate the therapeutic window for patients with cancer.
According to Greg Thurber, PhD, target-mediated uptake is the biggest driver of efficacy for antibody-drug conjugates as a cancer treatment.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to expect at the 43rd Annual Chemotherapy Foundation Symposium, such as new chemotherapeutics and targeted therapies.
In neuroendocrine tumor management, patients with insulinoma may be at risk of severe hypoglycemia following receipt of GLP-1 receptor agonists.
Related Content